MENU
+Compare
SRTOY
Stock ticker: OTC
AS OF
Sep 17 closing price
Price
$22.04
Change
+$2.14 (+10.75%)
Capitalization
19.94B

SRTOY stock forecast, quote, news & analysis

Sartorius Stedim Biotech is a leading provider of bioprocessing solutions... Show more

SRTOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SRTOY with price predictions
Sep 24, 2025

Momentum Indicator for SRTOY turns positive, indicating new upward trend

SRTOY saw its Momentum Indicator move above the 0 level on September 17, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator turned positive. In of the 48 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SRTOY just turned positive on September 16, 2025. Looking at past instances where SRTOY's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

SRTOY moved above its 50-day moving average on September 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRTOY crossed bullishly above the 50-day moving average on September 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for SRTOY moved below the 200-day moving average on September 16, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRTOY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SRTOY broke above its upper Bollinger Band on September 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRTOY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.533) is normal, around the industry mean (10.793). P/E Ratio (80.765) is within average values for comparable stocks, (55.895). Projected Growth (PEG Ratio) (1.012) is also within normal values, averaging (1.720). Dividend Yield (0.003) settles around the average of (0.016) among similar stocks. P/S Ratio (6.274) is also within normal values, averaging (13.997).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRTOY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Dividends

SRTOY paid dividends on April 21, 2025

Sartorius Stedim Biotech SRTOY Stock Dividends
А dividend of $0.08 per share was paid with a record date of April 21, 2025, and an ex-dividend date of April 04, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Align Technology (NASDAQ:ALGN).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 11.14B. The market cap for tickers in the group ranges from 246 to 157.06B. ISRG holds the highest valuation in this group at 157.06B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was -2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 8%. EKSO experienced the highest price growth at 14%, while CUPR experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -4%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 64
Price Growth Rating: 60
SMR Rating: 81
Profit Risk Rating: 91
Seasonality Score: -33 (-100 ... +100)
View a ticker or compare two or three
SRTOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Otto-Brenner-Strasse 20
Phone
+49 5513080
Employees
10662
Web
https://www.sartorius.com